DePuy Orthopaedics, a division of Johnson & Johnson, announced a recall in August of 2010 for two of its hip replacement products after many patients reported injuries from the flawed all-metal implants and early device failure. The now-recalled defective DePuy devices are known as Articular Surface Replacement (A.S.R.) and were available in two versions: the A.S.R. XL Acetabular System and the A.S.R. Hip Resurfacing System.
The two versions of the DePuy A.S.R. varied being that the A.S.R. XL Acetabular System was for use in traditional style hip replacements while the A.S.R. Hip Resurfacing System was for hip resurfacing, an alternative procedure. Of both versions, only the conventional A.S.R. XL Acetabular System was sold in the United States. However, both versions were sold throughout the world including Germany, the United Kingdom, and elsewhere in Europe. Both versions of the hip implant are metal-on-metal hip devices that have now been shown to be faulty. Other similar all-metal implants have also proven defective such as a device from Stryker. About 93,000 people worldwide, beginning in the early 2000s, were treated with the DePuy hip implants before they were recalled in late 2010. One-third of these 93,000 patients are in the United States while the other two-thirds are throughout the world including Germany and England. Urban Thier & Federer, P.A. is an international law firm currently actively involved in the lawsuits and can help you whether you are in the US or abroad.
DePuy recalled devices as patients were reporting high early failure rates of the hip implants yet internal reports note the company was long aware of the flawed design. Typical hip implants usually last over 15 years while the DePuy A.S.R. was lasting less than five years for a large number of patients. Medical professionals were told to stop using the faulty devices, but it was already too late for patients who had the metal hips implanted. Recipients of the DePuy hip implant often require revision surgery to remove and replace the defective device, as well as monitoring for metal toxicity.
Early failure of the DePuy metal-on-metal device has led many patients to experience painful side effects including fractures, dislocation, difficulty walking, and, most seriously, the generation of metallic debris from the cobalt and chromium of the implant that can lead to tissue damage. The excess levels of metal in the body produced by the hip implant can then lead to other side effects reported by the F.D.A. and by Arthritis Research UK that may include erosion of bone, deafness, blindness, or severe other nerve damage. Even if you are not experiencing side effects at this time, it is important to take prompt legal action to protect and enforce your constitutional rights.
Patients who have the DePuy A.S.R. XL Acetabular System or the A.S.R. Hip Resurfacing System, or another metal hip implant such as a Stryker hip implant, may be entitled to a claim including financial compensation. Urban Thier & Federer, P.A. encourages all patients potentially affected by this recall to seek competent legal counsel immediately. Please contact our Orlando, Florida office or use our “Contact Us” website located on the right-hand side of this article to discuss your rights with one of our attorneys.
Urban Thier & Federer, P.A. is currently actively involved in enforcing claimants’ legal rights, which must be timely made as part of the complex federal court litigation pending in the United States District Court for the Northern District of Ohio and styled In RE: DePuy ORTHOPAEDICS, INC. ASR HIP IMPLANT PRODUCTS.